Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Debra H. Weiner"'
Autor:
Susana N. Asin, Gustavo F. Doncel, Jill L. Schwartz, Christiane Rollenhagen, Christine K. Mauck, Sharon L. Hillier, Vivian Brache, Neelima Chandra, Raina N. Fichorova, Debra H. Weiner, Betsy C. Herold, Andrea R. Thurman, Beatrice A. Chen
Publikováno v:
AIDS Research and Human Retroviruses. 35:853-864
Reproductive age women may choose to concurrently use topical antiretrovirals and hormonal contraceptives (HCs) to simultaneously prevent HIV-1 infection and unintended/mistimed pregnancy. There are conflicting data on the effect of HCs on mucosal su
Autor:
Jill L. Schwartz, Andrea R. Thurman, Gustavo F. Doncel, Debra H. Weiner, Angela D. M. Kashuba, Neelima Chandra, Vivian Brache, Beatrice A. Chen, Christine K. Mauck
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 80:79-88
Endogenous and exogenous contraceptive hormones may affect mucosal pharmacokinetics (PKs) of topical antiretrovirals such as tenofovir. We present PK data from healthy women using tenofovir vaginal gel, at baseline (follicular and luteal phases) and
Autor:
Adedapo O Bashorun, Debra H. Weiner, Steve Lamola, Jorge Flores, Beate Kampmann, Mariama Badjie Hydara, Ikechukwu Adigweme, Andi Tate, David Goldblatt, Ed Clarke, Rajeev M. Dhere, Mark R. Alderson, Ama Umesi, Michael Okoye, Vistasp Sethna
Publikováno v:
Vaccine. 38(2)
Background A more affordable pneumococcal conjugate vaccine (PCV) that provides comparable protection to current PCVs is needed to ensure sustainable access in resource-limited settings. Serum Institute of India Pvt. Ltd.’s PCV candidate (SIIPL-PCV
Autor:
Shelly Fischer, Stephanie Combes, Catherine Hart, Debra H. Weiner, Peter Cherutich, Jaim Jou Lai, Robert C. Bailey, Paul J. Feldblum, Walter Obiero, Elijah Odoyo-June
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Objectives: To explore factors associated with healing requiring more than 6 weeks after placement of the PrePex device for adult medical male circumcision. Methods: We enrolled 427 men ages 18–49 years in an observational study of PrePex at 1 urba
Autor:
Lynn Bradley, David F. Archer, Jill L. Schwartz, Kurt T. Barnhart, Ron G. Frezieres, Christine K. Mauck, Debra H. Weiner, Maggie Kilbourne-Brook, Alfred N. Poindexter, Jaim Jou Lai, Mitchell D. Creinin, Marianne M. Callahan
Publikováno v:
Obstetrics & Gynecology. 125:895-903
OBJECTIVE:: To estimate contraceptive efficacy safety acceptability and fit of a single-size diaphragm used with contraceptive gel. METHODS:: We conducted a multicenter trial in which 450 couples used the single-size diaphragm 300 randomized to acid-
Autor:
Gustavo F. Doncel, Vivian Brache, Jill L. Schwartz, Raina N. Fichorova, Debra H. Weiner, Betsy C. Herold, Neelima Chandra, Andrea R. Thurman, Susana N. Asin, Mark A. Marzinke, Timothy J. McCormick, Charlene S. Dezzutti, Frank Z. Stanczyk, Sharon L. Hillier, Meredith R. Clark, Christiane Rollenhagen, Patrick F. Kiser
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 6, p e0199778 (2018)
PLoS ONE, Vol 13, Iss 6, p e0199778 (2018)
To prevent the global health burdens of human immunodeficiency virus [HIV] and unintended/mistimed pregnancies, we developed an intravaginal ring [IVR] that delivers tenofovir [TFV] at ~10mg/day alone or with levonorgestrel [LNG] at ~20μg/day for 90
Publikováno v:
Contraception. 89:31-35
Background The abdomen and thigh are recommended injection sites in the label for Depo-SubQ Provera 104™. We evaluated the pharmacokinetic profile of medroxyprogesterone acetate (MPA) following injection of Depo-SubQ Provera 104 in the upper arm, a
Autor:
Gustavo F. Doncel, Marianne M. Callahan, David F. Archer, Sharon L. Hillier, Raina N. Fichorova, Debra H. Weiner, Neelima Chandra, Christine K. Mauck, Jill L. Schwartz, Jaim Jou Lai, Charlene S. Dezzutti, Mitchell D. Creinin
Publikováno v:
AIDS Research and Human Retroviruses. 29:1475-1486
Several microbicides, including nonoxynol-9 (N-9) and cellulose sulfate (CS), looked promising during early trials but failed in efficacy trials. We aimed to identify Phase I mucosal safety endpoints that might explain that failure. In a blinded, ran
Autor:
Neetha S. Morar, Deborah Kacanek, van der Straten A, Meldrum M, Busisiwe Nkala, Villela Wv, Callahan M, Goihman S, Spellacy Wn, Debra H. Weiner, Nuriye Nalan Sahin-Hodoglugil, Phillip J, Rosalie Dominik, Loeber O, Mauck C, do Lago Tg, Alexander Nj, Elizabeth T. Montgomery, Barbosa Rm, Amanda Dennis, Kalckmann S, Sibongile Mtetwa, Watadzaushe C
Publikováno v:
The European Journal of Contraception & Reproductive Health Care. 17:89-92
This fact sheet describes PATHs work to expand access to family planning products and services in low-resource settings.
Autor:
Marianne M. Callahan, Kurt T. Barnhart, Mitchell D. Creinin, Debra H. Weiner, Christine K. Mauck, Alfred N. Poindexter, Angie Wheeless, Jill L. Schwartz, Maggie Kilbourne-Brook
Publikováno v:
Contraception. 78:465-473
Background Only one female condom [FC1 Female Condom (FC1)] is currently marketed, but it is poorly utilized, perhaps due to difficulty with insertion, discomfort and suboptimal functional performance during intercourse. The Program for Appropriate T